SWKH News and Press, SWK Holdings Corporation From 01/23/20

DALLAS , Jan. 23, 2020 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH), a life science focused specialty finance company, today announced that its shares of common stock will begin trading on the Nasdaq Capital Market beginning today at 9:30 a.m., EST under the ticker symbo...

DALLAS , Jan. 21, 2020 /PRNewswire/ -- SWK Holdings Corporation (SWKH.OB) ("SWK" or the "Company"), a life science focused specialty finance company, today announced that its shares of common stock have been approved for listing on the Nasdaq Capital Market. Trading on the exchange i...

BOONTON, N.J. , Dec. 6, 2019 /PRNewswire/ --  Enteris BioPharma, Inc. , a biotechnology company developing innovative drug products built around its proprietary delivery technologies and a wholly-owned subsidiary of SWK Holdings Corporation (SWKH.OB), congratulates Cara Therapeutics ...

The following slide deck was published by SWK Holdings Corporation in conjunction with this Read more ...

DALLAS , Nov. 21, 2019 /PRNewswire/ -- SWK Holdings Corporation (SWKH.OB) ("SWK" or the "Company"), a life science focused specialty finance company, announced today that Winston Black , Chief Executive Officer of SWK, has been named Chairman of the Company's Board of Directors...

SWK Holdings ( OTCQB:SWKH ): Q3 Non-GAAP EPS of $0.39; GAAP EPS of $0.32. Revenue of $6.35M (+8.0% Y/Y) Press Release More news on: SWK Holdings Corporation, Earnings news and commentary, Financial stocks news, ,

DALLAS , Nov. 18, 2019 /PRNewswire/ -- Corporate Highlights Acquired Enteris BioPharma, Inc. ("Enteris") a biotechnology company offering innovative formulation solutions utilizing its proprietary oral drug delivery technology, Peptelligence® Enteris to operate as an indepe...

DALLAS , Sept. 16, 2019 /PRNewswire/ -- SWK Holdings Corporation (SWKH.OB) ("SWK" or the "Company"), a life science focused specialty finance company, announced that CEO Winston Black will present at the Fall Investor Summit being held today in New York City . Details of SWK's prese...

DALLAS , Sept. 6, 2019 /PRNewswire/ -- SWK Holdings Corporation (SWKH.OB) ("SWK" or the "Company"), a life science focused specialty finance company, today announced that its Board of Directors has authorized the Company to repurchase up to an aggregate of $2.1 million of the Compa...

DALLAS , Sept. 3, 2019 /PRNewswire/ -- SWK Holdings Corporation (SWKH.OB) ("SWK" or the "Company"), a life science focused specialty finance company, announced today that the Company has submitted its formal application to list its common shares on the NASDAQ Capital Market. Concu...